Letters
Non-commercial clinical trials
A step change in operational performance is needed
BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c5472 (Published 13 October 2010) Cite this as: BMJ 2010;341:c5472
- Jon Moulton, trustee ,
- Ashley Woodcock, head of School of Translational Medicine, University of Manchester,
- Helen P Critchley, senior clinical research associate
- 1JP Moulton Charitable Foundation, Sevenoaks, Kent TN14 7SD, UK
- hpcritchley{at}yahoo.com
The JP Moulton Charitable Foundation began funding non-commercial clinical trials in April 2004. Applications had to demonstrate good scientific rationale, expertise in the area of research, clear budget breakdowns, and achievable targets. If funding was approved, the foundation requested a detailed breakdown of costs, milestones for payment against recruitment, detailed quarterly progress reports, and …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.